Re: Checklist / F&A costs Dolce, Peter J 18 Aug 2005 12:51 EST
NIH, right? You list only the applicant organization's F & A rate. In most collaborative arrangements, the subawardees are pretty much invisible to the sponsor; the condition of "privity" (hope I'm using this correctly) exists between the sponsor and the applicant organization, not between the sponsor and subawardees. PJD **************************************************************** Peter J. Dolce, Ph.D. Associate Vice President for Research Grants Management and Compliance 1005 D. B. Todd Boulevard Meharry Medical College Phone 615 327 6225 Fax 615 327 6716 Nashville, TN 37208 -----Original Message----- From: Research Administration List [mailto:xxxxxx@HRINET.ORG] On Behalf Of Robert Miller Sent: Thursday, August 18, 2005 12:40 PM To: xxxxxx@HRINET.ORG Subject: [RESADM-L] Checklist / F&A costs Master-budgeteers... One of my PI's seems to think that when completing the checklist (non competing continuation) you must separately list the F&A of the consortium contract (on the check list). I disagree, the instructions does not state so as the direct costs of the primary encompasses the F&A of the consortium contract. Your input would help. Thanks Robert Gregory Miller Charles R. Drew University of Medicine and Science Div. of Endocrinology, Metabolism and Molecular Science Administrative Director/Research Administrator xxxxxx@cdrewu.edu Office: 323.563.5961 Fax: 323.563.5966 Notice of Confidentiality This message contains information that may be confidential or privileged. It is intended for the exclusive use of the addressee or any person entitled to receive it. If you received this message in error, please inform the author as soon as possible, do not disclose its contents and delete it from your system ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== DISCLAIMER: This email and any files transmitted with it may be privileged, confidential, and contain health information that is legally protected. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless permitted to do so by law or regulation. If you are not the intended recipient, you are hereby notified that any use, disclosure, copying, or distribution, is strictly prohibited. If you have received this information in error, please notify the sender immediately and arrange for the return or destruction of these documents. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================